Healthcare & Life Sciences

At Hilco Valuation Services Europe, our experienced team are on hand to provide informed advice for the Healthcare & Life Sciences industry.

Our dedicated team can provide advice to those operating in this sector.

Equipment & Supplies

Equipment and Supplies in the Healthcare and Life Sciences sector represents a vast, lucrative market with the potential for career defining deals to be made. With billions of people on this planet and ageing populations the norm in developed nations, the demand for these products is ever increasing. Hilco know that supplying either enough volume of low value products to fulfil a contract or investing in the costly production of accurate scientific equipment requires a constant stream of capital. Equally as important is the investment in innovation and product development, which is a long-term investment, meaning costs will not be recovered quickly, again representing a large capital outlay.

Our team know that in this industry proper management of assets to maximise efficiency or valuations used to secure lending is vital in allowing companies to grow to fulfil larger contracts or to consolidate efforts on profitable areas of business.

Providers & Services

Within healthcare, Providers and Services represents the secondary or tertiary sector. They are owners and operators of private health facilities including hospitals, managed care facilities, dental practises, and charitable organisations. Whilst the provision of healthcare and services can be lucrative, private providers of these services can often struggle with the effect of the efficiency of scale.  Private providers need to ensure that they are monitoring supply chains, regularly performing maintenance of equipment, record keeping, forecasting and budgeting with a small team or even a single decision maker.

Hilco can be a trusted partner to our clients in this sector whether through asset tagging asset life cycle management, valuation for insurance or lending purposes or even end of life strategies for assets.

Biotechnology

Hilco understand that the market for biotechnology is vast. This market, by its nature, requires regulation and trials to protect public health which results a capital-intensive environment to produce innovation. For those who are able to get products to market there are billions to be made. Companies that operate in this sector will require a great deal of physical assets which will be greatly valuable.

We can aid our clients in managing their assets throughout their lifecycles, providing accurate valuation for lending, insurance or asset-based lending. When an asset has reached the end of its useful life with our clients Hilco can also provide end of life strategies to ensure that these assets are handled in the proper way.

Pharmaceuticals

The Pharmaceuticals industry is a chemistry-based industry which focuses on scientific innovation and the production of medications that are intended to alleviate suffering or cure illness. As with most industries which produce a product for human consumption, strong regulation is present in this industry. Research and development in this industry is also regulated and capital intensive. Our clients in the pharmaceuticals industry are working everyday with business assets that make up a large portion of the companies wealth.

Hilco Valuation Services Europe can aid our clients in managing their assets throughout their life cycles, providing accurate valuation for lending, insurance or asset-based lending. When an asset has reached the end of its useful life with our clients, Hilco can also provide end of life strategies to ensure that these assets are handled in the proper way.

Cosmetics

The Cosmetics industry represents a market worth hundreds of billions of what ever currency you care to choose globally. Cosmetics most likely will immediately conjure notions of makeup and other such beauty products but cosmetics range from antiperspirants to toothpastes to sunscreens. In essence any form of personal care product that will be used daily is a cosmetic good. Therefore, it stands to reason that even a fairly low markup good can generate a considerable revenue stream for its manufacturer. This market when viewed in its full panorama can vary from a single individual who produces low volumes of a boutique product to the massive conglomerates that span across every global market.

We know that to our clients, the ability to secure lines of credit through asset-based lending based on trusted valuations and optimised end of life strategy for assets is vital. This is capital that can be better utilised in research and development, marketing or even as a measure to improve cash flow. Hilco Valuation Services are a trusted partner to our clients supporting them in making the right decisions at the right time for their business.

AN IN-DEPTH LOOK AT OUR WORK IN ACTION

Smartlife

Hilco Streambank was appointed by Ben Woodthorpe and Simon Jagger of ReSolve Advisory Limited, the Joint Administrators of Rosnes Limited…

Learn More

Contacts

Contact our experienced team to find out how we can utilise our combined asset expertise to your advantage.

Chris Hall

CEO

London Office

+44 (0) 7795 832658

chall@hilcoglobal.eu

Jason Hall Assoc. RICS

Partner

Machinery & Business Assets

Leeds Office

+44 (0) 7917 724464

jhall@hilcoglobaladvisors.co.uk

Mark Newman

Managing Director

Inventory

Leeds Office

+44 (0) 7920 149076

mnewman@hilcoglobaladvisors.co.uk